Unichem Lab Gets Tentative Nod for Tadalafil Tablets

Unichem Lab has received a tentative approval from the US health regulator for generic Tadalafil tablets used for treatment of erectile dysfunction. The company has received the tentative approval from the United States food and Drug Administration for its Tadalafil tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Unichem Laboratories said in a filing to the BSE. The tablets are used for treatment of erectile dysfunction (ED), signs and symptoms of benign prostatic hyperplasia (BPH), Unichem Laboratories said. The product is a generic version of Eli Lilly’s Cialis tablets in the same strengths. – Medical Buyer Bureau